Nimotuzumab: clinical trials recruiting now
3
Recruiting trials
3
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 3
Conditions being studied
| Condition | Trials |
|---|---|
| Pancreatic Cancer · Nimotuzumab for Pancreatic Cancer | 3 |
| Metastatic Pancreatic Carcinoma | 1 |
| Pancreatic Cancer Resectable | 1 |
Recruiting trials involving Nimotuzumab
- HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
- Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
- Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
Common questions
How many recruiting trials involve Nimotuzumab?
3 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.